Texas-based biotechnology firm Gameto developed a more accessible alternative to in vitro fertilization called Fertilo. Instead of relying on hormone injections to mature eggs, it uses ovarian support cells (OSC) to promote egg maturation in a laboratory. On December 16, 2024, the biotech company announced the birth of the first Fertilo baby. Dr. Luis Guzmán,
